Fosun Pharma, TPG make China healthcare move

Take-private bid for Chindex offers US private equity group exposure to China's burgeoning healthcare sector.

Fosun Pharma, TPG make China healthcare move

Shanghai Fosun Pharmaceutical Fosun Pharma and US private equity firm TPG have made an offer to take Nasdaq-listed healthcare company Chindex private in a $369 million deal.

The move offers TPG the chance to gain exposure to China's growing healthcare sector, an area that the government has been loosening restrictions on.

It also will enable the Chinese group’s management to partner two deep-pocketed players in its expansion drive.


FinanceAsia has updated its subscription model. Registered readers now have the opportunity to read five articles from our award-winning website for free. Please subscribe for unlimited access.

Click for more on: fosun pharma | tpg | chindex

Print Edition

FinanceAsia Print Edition